Investor Information

2007 Press Releases

The information and content in this site has been released in the past by Express Scripts Holding Company or its predecessor and wholly-owned subsidiary, Express Scripts, Inc. (together, Express Scripts). These contents may no longer be current. The passage of time can render information stale, and you should not rely on the continued accuracy of any such material beyond the date of issuance. On the date released, some of the contents in this site may have contained statements that were then "forward-looking statements," based upon then current expectations, forecasts and assumptions that involved risks and uncertainties, then enumerated by Express Scripts that could cause actual outcomes and results to differ materially. To the extent any information is forward-looking, it is intended to comply with the safe harbor for forward-looking information as of the date of issuance (for more information, view our forward-looking statement). Express Scripts disclaims any intention or obligation to update or revise the contents of this site, including but not limited to any forward-looking statements made at the time the information was first released, whether as a result of new information, future events or otherwise.

Keyword Search


Archived Press Releases
2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
11/27/2007Express Scripts Provides 2008 Earnings Per Share Guidance
Reflects Growth of 22% to 25% ST. LOUIS--(BUSINESS WIRE)--Nov. 27, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced today that it believes its financial performance will continue to benefit from the growth in generic utilization, home delivery, and specialty pharmacy management; lower retail and home delivery drug purchasing costs; increased productivity; and capital structure improvements. As a result, the Company expects its 2008 diluted earnings per share will be in the ra... 
11/20/2007Express Scripts Announces 2008 Earnings Guidance Conference Call
ST. LOUIS--(BUSINESS WIRE)--Nov. 20, 2007--Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its 2008 earnings guidance on Tuesday, November 27, 2007 before the market opens and hold a conference call on this day to discuss this guidance at 8:30 a.m. Central (9:30 a.m. Eastern). This call is being webcast and can be accessed at Express Scripts' web site at http://www.express-scr... 
11/20/2007Express Scripts to Expand at University of Missouri-St. Louis
ST. LOUIS--(BUSINESS WIRE)--Nov. 20, 2007--Express Scripts Inc. announced today it will build a second office building at University Place/NorthPark, the Business, Technology and Research Park of the University of Missouri-St. Louis (UMSL). Construction is expected to be completed in December 2008. The new building will be adjacent to Express Scripts' Headquarters, which was completed in May 2007. Criteria for selecting the UMSL campus for the recently built headquarters location ... 
11/06/2007Express Scripts to Present at Investor Conferences
ST. LOUIS--(BUSINESS WIRE)--Nov. 6, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Credit Suisse Health Care Conference on November 14, 2007 at 8:00 a.m. MST (10:00 a.m. EST) at the Arizona Biltmore Hotel in Phoenix, Arizona. Merrill Lynch Health Services Conference on November 28, 2007 at 10:45 a.m. EST at the Merrill Lynch World Financial Center Headquarters in New York, NY. These presentations will also be broad... 
10/24/2007Express Scripts Reports a 43 Percent Increase in Adjusted Earnings Per Share
2007 Earnings Per Share Guidance Increased -- Midpoint Reflects 39 Percent Growth Record Third Quarter Cash Flow From Operations of $247 million ST. LOUIS, Oct. 24, 2007 (PRIME NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced third quarter net income of $142.9 million, or $0.56 per diluted share, which includes non-recurring charges totaling $0.04 per diluted share discussed below. Excluding these charges, diluted earnings per share was $0.60, a 43... 
10/11/2007Express Scripts Acquires Industry Leading CDHP Account Administrator
ConnectYourCare Aids Strategy of Enabling Better Health and Value at the Consumer Level ST. LOUIS--(BUSINESS WIRE)--Oct. 11, 2007--Pharmacy benefit manager Express Scripts, Inc., (NASDAQ: ESRX) today announced the acquisition of ConnectYourCare, L.L.C., one of the nation's leading consumer directed health plan (CDHP) account administrators, from privately-held Revolution Health. Terms of the transaction were not disclosed. ConnectYourCare, based near Baltimore,... 
10/03/2007Express Scripts Earns New URAC Accreditation
ST. LOUIS--(BUSINESS WIRE)--Oct. 3, 2007--Express Scripts today announced it has earned accreditation under the new pharmacy benefit management (PBM) accreditation program established by URAC, the Washington D.C.-based independent accreditor of health care management organizations. URAC launched the new accreditation program to create standards that promote PBM industry best practices, encourage quality improvement, and protect and empower consumers. The accreditation standar... 
09/27/2007Express Scripts, Inc. Third Quarter 2007 Earnings Conference Call
ST. LOUIS--(BUSINESS WIRE)--Sept. 27, 2007--Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its third quarter earnings on Wednesday, October 24, 2007 after 4:00 p.m. Eastern (3:00 p.m. Central Time) and will hold its quarterly conference call to discuss third quarter results on Thursday, October 25, 2007, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). This call is being webcas... 
09/12/2007Express Scripts to Present at Bank of America Conference
ST. LOUIS--(BUSINESS WIRE)--Sept. 12, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Bank of America 37th Annual Investment Conference on September 19, 2007 at 9:30 a.m. pacific (12:30 p.m. eastern) at Ritz-Carlton Hotel in San Francisco, CA. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Playe... 
09/05/2007Express Scripts to Webcast Investor Meeting
ST. LOUIS--(BUSINESS WIRE)--Sept. 5, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced that it has scheduled an investor meeting in New York beginning at 9:00 a.m. eastern on Thursday, October 4, 2007, at which management will make presentations regarding the Company. The presentation will be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Player is ne... 
07/30/2007Express Scripts Participates in New PBM Accreditation Program
ST. LOUIS--(BUSINESS WIRE)--July 30, 2007--Express Scripts announced today its participation in the beta testing process for a new program to establish accreditation standards for pharmacy benefit managers. URAC, the Washington, D.C.-based independent accreditor of health care management organizations, is launching the program with the goal of creating standards that promote the pharmacy benefit management (PBM) industry best practices; encourages quality improvement; and protects and... 
07/25/2007Express Scripts Reports Strong Second Quarter Earnings
Company Raises 2007 Earnings Per Share Guidance; Announces Increase in Share Repurchase AuthorizationST. LOUIS, Jul 25, 2007 (PrimeNewswire via COMTEX News Network) -- Express Scripts, Inc. (Nasdaq:ESRX) announced second quarter net income of $152.7 million, or $0.57 per diluted share. Excluding a non-recurring gain on the sale of stock that is discussed below, earnings per diluted share was $0.56, a 47 percent increase over $0.38 per diluted share for the same quarter last year. All per share a... 
07/12/2007Express Scripts Study Links Use of Generic Drugs to Generic-Brand Copay Differentials
ST. LOUIS, Jul 12, 2007 (BUSINESS WIRE) -- In the first study of its kind, pharmacy benefit manager Express Scripts' researchers have established a link between encouraging the use of more generic drugs and the copay differential between generics and brand drugs. Plans with a generic vs. brand copayment differential of $21 or more used generic drugs at a rate 5.2 percentage points higher than plans with a $0 to $5 differential. "The findings in this study show that getting plan design rig... 
07/03/2007Express Scripts, Inc. Second Quarter 2007 Earnings Conference Call
ST. LOUIS--(BUSINESS WIRE)--July 3, 2007--Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its second quarter earnings on Wednesday, July 25, 2007, after 3:00 p.m. Central Time. In addition, management will holds its quarterly conference call to discuss second quarter results on Thursday, July 26, 2007 at 9:00 a.m. Central Time. This call is being webcast by Thomson Financial a... 
06/07/2007Express Scripts to Present at Investor Conferences
ST. LOUIS--(BUSINESS WIRE)--June 7, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences in June 2007: Goldman Sachs 28th Annual Global Healthcare Conference on June 14, 2007 at 8:00 a.m. pacific (11:00 a.m. eastern) at the Ritz Carlton in Laguna Nigel, CA. William Blair 27th Annual Growth Stock Conference on June 19, 2007 at 9:50 a.m. central (10:50 a.m. eastern) at the Four Seasons Hotel in Chicago, IL. Jeffries Healthc... 
05/23/2007Express Scripts Declares 2-For-1 Stock Split
ST. LOUIS--(BUSINESS WIRE)--May 23, 2007--Express Scripts, Inc. (NASDAQ: ESRX) today announced that its Board of Directors has approved a two-for-one stock split to be effected in the form of a stock dividend. The stock split is for shareholders of record as of June 8, 2007, and will be effective on or about June 22, 2007. "Our stock split reflects the successful execution of our business model, which is built around the alignment of interests with plan sponsors and patients," sta... 
05/17/2007Express Scripts to Present at Investor Conferences
ST. LOUIS, May 17, 2007 (BUSINESS WIRE) -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences: Citigroup Healthcare Conference on May 24, 2007 at 12:00 p.m. eastern at The New York Hilton Hotel in New York, NY. Bank of America 2007 Health Care Conference on May 30, 2007 at 10:00 a.m. pacific (1:00 p.m. eastern) at the Four Seasons Hotel in Las Vegas, NV. These presentations will also be broadcast via the Internet and can be accessed on th... 
04/26/2007Consumer Outreach Boosts Generic Cholesterol-Fighting Drugs
Generic Use Up 500%, Saving $230 Million Since January '06 ST. LOUIS--(BUSINESS WIRE)--April 26, 2007--Benefit plan sponsors and patients have saved $230 million on cholesterol-fighting drugs since January 2006, when Express Scripts (Nasdaq: ESRX) began encouraging consumers to discuss generic alternatives with their physicians. The company, one of the nation's largest pharmacy benefit managers, reported the savings at its annual Outcomes Conference today. Use of generic chol... 
04/25/2007Nearly One Quarter of Seniors Could Have Avoided Medicare ''Doughnut Hole''
Analysis Uncovers Opportunity to Steer Clear of Prescription Coverage Gap and Cut Overall Medicare Part D Costs by 13 Percent Through Increased Use of Generic Drugs ST. LOUIS--(BUSINESS WIRE)--April 25, 2007--Express Scripts (Nasdaq: ESRX), a leading pharmacy benefit manager, today announced results of an analysis examining the 2006 prescription claims history of 220,000 non-low-income seniors with Medicare drug plans that have a standard coverage gap, "doug... 
04/25/2007Biotech Drug Spending Increases 21 Percent Even as Growth in Rx Expenditure Slows
Study Predicts Category Will Account for $99 Billion by 2010 ST. LOUIS--(BUSINESS WIRE)--April 25, 2007--Express Scripts (Nasdaq: ESRX), a leading pharmacy benefit manager, today announced spending on high-cost biotech drugs increased 21 percent in 2006. This increase excludes spending for biotech drugs within the medical benefit, such as those administered in physician offices or other therapies that traditionally fall into the medical benefit. Spending increased 25 percent in 20... 
04/23/2007Express Scripts Reports Strong First Quarter Earnings
Company Raises 2007 Guidance for Both Earnings Per Share and Cash Flow ST. LOUIS--(BUSINESS WIRE)--April 23, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced first quarter net income of $133.7 million, or $0.97 per diluted share. Excluding non-recurring items that are discussed below, earnings per diluted share was $1.04, a 49 percent increase over $0.70 per diluted share for the same quarter last year. Express Scripts reported first quarter cash ... 
04/23/2007Express Scripts Nominates Woodrow A. Myers to Board of Directors
ST. LOUIS--(BUSINESS WIRE)--April 23, 2007--Express Scripts, Inc., today announced the nomination of Woodrow A. Myers, M.D., M.B.A., for election to the company's Board of Directors at its May 23, 2007, annual meeting. Currently managing director of Myers Ventures LLC, Dr. Myers most recently served as executive vice president and chief medical officer of Wellpoint Health Networks, Inc., from 2000 to 2005. Previously, he served as director, healthcare management for Ford Motor Com... 
04/20/2007Express Scripts' Workers' Compensation Program Increases Use of Generic Drugs
ST. LOUIS--(BUSINESS WIRE)--April 20, 2007--ExpressComp, a workers' compensation offering by Express Scripts, increases the use of generic medications and reduces clients' costs. Express Scripts is one of the largest pharmacy benefit managers (PBM) in North America. Express Scripts is a leader in consumer behavioral changes involving the use of generic drugs. Since 2001, generic drug utilization for Express Scripts' workers' compensation clients has grown from 52 percent of all pr... 
04/17/2007Study Shows CDHP Financial Incentives Not Enough to Change Consumer Behavior
Better Communications, Tools Needed to Help Consumers Save Money, Promote Health ST. LOUIS--(BUSINESS WIRE)--April 17, 2007--Consumer-Directed Health Plans (CDHP) require more than financial incentives to help consumers make smart choices about their health and prescription use, according to a new study by pharmacy benefit manager Express Scripts. CDHP participants were, in fact, less likely than traditional health plan enrollees to change behavior an... 
04/04/2007Online COB Program for DoD Receives Innovation Award
ST. LOUIS--(BUSINESS WIRE)--April 4, 2007--The U.S. Department of Defense (DoD) TRICARE Retail Pharmacy (TRRx) program received the Pharmacy Benefit Management Institute's 2007 Rx Benefit Innovation award for its online, real-time coordination of benefits (COB) program, which is managed by Express Scripts and other DoD contractors. Express Scripts is one of the nation's largest pharmacy benefit management companies. "We congratulate the DoD on receiving this recognition and we are... 
03/23/2007Express Scripts Schedules First Quarter 2007 Earnings Conference Call
ST. LOUIS--(BUSINESS WIRE)--March 23, 2007--Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its first quarter earnings on Monday, April 23, 2007 after 3:00pm Central Time and will hold its quarterly conference call to discuss first quarter results on Tuesday, April 24, 2007, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed at Express... 
03/16/2007Express Scripts Positioned for Strong Growth After Caremark Vote
Innovation and Execution Delivers Value for Stockholders, Plan Sponsors and Patients ST. LOUIS, March 16 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today issued the following statement from president, chief executive officer and chairman George Paz commenting on the approval by Caremark Rx, Inc. (NYSE: CMX) stockholders of Caremark's acquisition by CVS Corporation (NYSE: CVS). "First of all, I want to thank the stockhol... 
03/15/2007Express Scripts Reiterates Commitment to Raising Offer if Additional Synergies Identified
Advisory Services, Analysts, Stockholders Support Express Scripts Position Company Urges Caremark Stockholders to Vote GOLD Proxy Card AGAINST The Flawed Caremark Merger ProcessST. LOUIS, March 15, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today issued the following statement of commitment to an acquisition of Caremark Rx, Inc. (NYSE: CMX): Express Scripts is firmly committed to increasing the cash portion of our offer if we identify addition... 
03/14/2007Express Scripts Urges Caremark Stockholders Not to Leave Money on the Table
Urges Caremark Stockholders to Vote GOLD Proxy Card AGAINST The Flawed Caremark Merger Process ST. LOUIS, March 14 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today issued an open letter to Caremark Rx, Inc. (NYSE: CMX) stockholders urging them to vote against the proposed acquisition of Caremark by CVS Corporation (NYSE: CVS). Dear Caremark Stockholder: If you want more money, you should vote against the CVS transaction. ... 
03/14/2007Express Scripts to Present at the Lehman Brothers 2007 Global Healthcare Conference
ST. LOUIS--(BUSINESS WIRE)--March 14, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Lehman Brothers 2007 Global Healthcare Conference on March 19, 2007 at 8:30 a.m. EDT at the Loews Miami Beach Hotel in Miami, FL. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to listen to the ... 
03/14/2007Glass Lewis Reiterates Caremark Stockholders Should Vote Against CVS Acquisition
ST. LOUIS, March 14 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that Glass, Lewis & Co. ("Glass Lewis"), a leading independent voting advisory service, reiterated to its clients that Caremark stockholders should vote AGAINST the proposed acquisition of Caremark Rx, Inc., (NYSE: CMX) by CVS Corporation (NYSE: CVS) at Caremark's special meeting of stockholders on March 16, 2007. In its recommendation, Glass Lewis stated*: "As discus... 
03/13/2007PROXY Governance Recommends Caremark Stockholders Vote Against Acquisition By CVS
ST. LOUIS, March 13 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that PROXY Governance, Inc., a leading independent voting advisory service, recommends that its clients vote AGAINST the proposed acquisition of Caremark Rx, Inc., (NYSE: CMX) by CVS Corporation (NYSE: CVS) at Caremark's special meeting of stockholders on March 16, 2007. In its report, PROXY Governance noted: "We question whether Caremark's management and board negotiated the ... 
03/13/2007Express Scripts Comments on ISS Recommendation
ST. LOUIS, March 13 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today issued the following statement in response to the recommendation issued by Institutional Shareholder Services (ISS) regarding the proposed acquisition of Caremark Rx, Inc., (NYSE: CMX) by CVS Corporation (NYSE: CVS) at Caremark's special meeting of stockholders on March 16, 2007: "It is unfortunate that ISS has chosen not to support a disciplined and stockholder centric approach to this... 
03/12/2007Express Scripts Declares Current Offer to Acquire Caremark 'Best and Only' Offer Without Confirmatory Due Diligence
Identification of Additional Value Could Result in Higher Offer Price Caremark Stockholders Urged to Vote Against Flawed Merger Process with CVSST. LOUIS, March 12, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that the flawed merger process pursued by the Caremark Rx, Inc. (NYSE: CMX) Board of Directors, specifically the Board's refusal to permit confirmatory due diligence by Express Scripts, prevents Caremark stockholders from r... 
03/07/2007Express Scripts Improves Offer to Acquire Caremark
Raises 2007 Earnings Per Share Guidance Reflecting 26% to 29% GrowthST. LOUIS, March 7, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced an enhancement of its offer to acquire Caremark Rx, Inc (NYSE: CMX). The Express Scripts offer is to acquire all outstanding shares of Caremark for $29.25 in cash and 0.426 shares of Express Scripts stock for each share of Caremark stock. The Company will now pay additional cash consideration of ... 
03/06/2007Study Shows Specialty Pharmacy High Touch Model is Better for Patients
ST. LOUIS--(BUSINESS WIRE)--March 6, 2007--Patients using a specialty pharmacy for biotech medicines are more likely to report they are better able to manage their condition than those using a retail pharmacy by 42 percent versus 33 percent, according to a new study released by Express Scripts, a pharmacy benefit manager. Better results achieved by specialty pharmacy CuraScript can be attributed to its "high touch" care model. With the high touch care model, a patient's purchase o... 
02/28/2007Study Shows Incentive Program Increases Generic Drug Use
ST. LOUIS--(BUSINESS WIRE)--Feb. 28, 2007--A program that promotes greater use of generic medications, by waiving patient copayments for a limited time, is proven effective, according to a report released by Express Scripts, a leading pharmacy benefit manager. The report validates the effectiveness of the program - known as Zero Dollar Copay - in moving a significant number of plan members to lower cost, equally effective generics. Julayna Meyer, vice president of research and tre... 
02/23/2007Express Scripts Comments on Delaware Court of Chancery Ruling
Court Again Enjoins Caremark Vote on Acquisition by CVS, This Time for at Least 20 Days Recognizes Caremark Stockholders Have Appraisal Rights ST. LOUIS, Feb. 23 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today commented on the ruling by the Court of Chancery of the State of Delaware that it has again enjoined Caremark Rx, Inc. (NYSE: CMX) from holding a stockholder vote regarding the CVS acquisition, this time un... 
02/15/2007Generic Biotech Medicines Could Save Plan Sponsors and Patients $71 Billion
ST. LOUIS, Feb 15, 2007 (BUSINESS WIRE) -- Generic biotech medicines could save U.S. plan sponsors and patients $71 billion over ten years, with $3.5 billion of the savings occurring the first year, according to a report issued by Express Scripts, one of the nation's largest managers of pharmacy benefit plans. Savings for plan sponsors could amount to $1,900 in the first year for a multiple sclerosis patient with a therapy treatment that includes biotech medicines. "Given the savings p... 
02/13/2007Express Scripts Comments on Delaware Court of Chancery Order
ST. LOUIS, Feb 13, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today noted the order by the Court of Chancery of the State of Delaware in support of an independent stockholder's motion to enjoin the Caremark Rx, Inc., (NYSE: CMX) February 20, 2007 special meeting of stockholders until at least March 9, 2007. The company commented: "This is the right decision for Caremark stockholders. It is unfortunate that it was necessary for a court to e... 
02/13/2007Express Scripts Comments on Revised CVS Offer
Urges Stockholders to Vote GOLD Proxy Card AGAINST Proposed CVS Transaction Now Express Scripts Extends Tender Offer to March 16, 2007 ST. LOUIS, Feb. 13 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today commented on CVS Corporation's (NYSE: CVS) revised offer to acquire Caremark Rx, Inc., (NYSE: CMX). The Company stated: "Today's announcement can't paper over a flawed process, weaker currency, and unproven strat... 
02/12/2007Generic Anti-Cholesterol Drugs Save $126 Million for Plan Sponsors, Patients
Shift to Generics Biggest in History for America's Most Used Drug Class ST. LOUIS, Feb. 12 /PRNewswire-FirstCall/ -- Generic anti-cholesterol drugs helped pharmacy benefit manager Express Scripts save $126 million for its plan sponsors and patients in 2006. The cholesterol fighting drug Zocor(R) became available as generic simvastatin on June 23, 2006. By that time, Express Scripts had already succeeded in giving its clients and patients a big head start on saving money with th... 
02/12/2007ISS Recommends Caremark Stockholders Vote Against Acquisition by CVS
Four Proxy Advisory Firms Recommend Caremark Stockholders Vote Against CVS TransactionST. LOUIS, Feb 12, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that Institutional Shareholder Services (ISS), a leading independent voting advisory service, recommends that its clients vote AGAINST the proposed acquisition of Caremark Rx, Inc., (NYSE: CMX) by CVS Corporation (NYSE: CVS) at Caremark's special meeting of stockholders on February... 
02/09/2007Express Scripts Urges Caremark Board to Negotiate
Mails Letter to Caremark BoardST. LOUIS, Feb 09, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today mailed the following letter to the Board of Caremark Rx, Inc. (NYSE: CMX): February 9, 2007 Board of Directors Caremark Rx, Inc. 211 Commerce Street, Suite 800 Nashville, Tennessee 37201 Ladies and Gentlemen: Since our initial proposal to you more than seven weeks ago, setting out the terms of... 
02/09/2007Express Scripts Urges Caremark Stockholders to Vote the GOLD Proxy Card AGAINST the Proposed CVS/Caremark Transaction Today
Mails Letter to Caremark Stockholders ST. LOUIS, Feb. 9 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today mailed the following letter to the stockholders of Caremark Rx, Inc. (NYSE: CMX): February 9, 2007 PROTECT YOUR CAREMARK INVESTMENT VOTE AGAINST THE PROPOSED CVS MERGER TODAY Dear Caremark Stockholder: For nearly eight weeks, Caremark's Board and management have stonewalled Express ... 
02/08/2007Express Scripts Reports Record Fourth Quarter and Full-year 2006 Earnings
Company Raises 2007 Guidance for Both Earnings Per Share and Cash Flow Announces Increase In Share Repurchase Authorization ST. LOUIS--(BUSINESS WIRE)--Feb. 8, 2007--Express Scripts, Inc. (Nasdaq: ESRX) announced record fourth quarter net income of $147.2 million, or $1.07 per diluted share, compared to $0.75 per diluted share for the same quarter last year. Excluding non-recurring items in both quarters that are discussed below, ear... 
02/05/2007Express Scripts Urges Caremark Stockholders to Ignore CVS and Caremark's Scare Tactics
Vote the GOLD Proxy Card AGAINST the Proposed CVS/Caremark Transaction TodayST. LOUIS, Feb 05, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today urged Caremark (NYSE: CMX) stockholders to reject the desperate scare tactics set forth in the CVS (NYSE: CVS) letter this morning. The letter represents a continuation of the attempts by both CVS and Caremark to distract attention from the real issue at stake -- to maximize value for Caremark stockho... 
02/02/2007Express Scripts Urges Caremark Stockholders to Reject Value Destruction of Proposed Acquisition by CVS
ST. LOUIS, Feb. 2 /PRNewswire-FirstCall/ -- In an advertisement published today in The Wall Street Journal, Express Scripts, Inc. (Nasdaq: ESRX) urged Caremark Rx, Inc. (NYSE: CMX) stockholders to consider the enhanced value that an Express Scripts/Caremark combination offers to stockholders, plan sponsors and patients. By contrast, the proposed acquisition of Caremark by CVS Corporation (NYSE: CVS) is strategically and financially flawed. The text of the advertisement follows: ... 
02/01/2007Express Scripts Mails Letter to Caremark Stockholders
Urges Caremark Stockholders to Vote AGAINST CVS Proposal ST. LOUIS, Feb. 1 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today mailed the following letter to the stockholders of Caremark Rx, Inc. (NYSE: CMX): February 1, 2007 PROTECT YOUR CAREMARK INVESTMENT VOTE AGAINST THE PROPOSED CVS MERGER Dear Caremark Stockholder: As the Caremark Special Meeting approaches, we urge you to carefully con... 
01/31/2007Express Scripts Comments on Caremark's Attempts to Defend Lavish Payments to its Senior Management
ST. LOUIS, Jan 31, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today commented on the statement made by Caremark Rx, Inc. (NYSE: CMX) in an advertisement published today. "It is outrageous that Caremark would spend stockholder money attempting to defend the lavish payments that its senior management would receive in a combination with CVS. We have trouble understanding how a 'merger of equals' could possibly warrant... 
01/31/2007Express Scripts Intends to Re-File Hart-Scott-Rodino Premerger Notification
ST. LOUIS, Jan. 31 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it intends to voluntarily withdraw on February 2, 2007, and will re-file on February 6, 2007, its notification under the Hart-Scott-Rodino Antitrust Improvements Act in connection with the proposed acquisition of Caremark Rx, Inc. (NYSE: CMX) by Express Scripts. Express Scripts has determined to withdraw its Hart-Scott-Rodino filing and re-file it, which will provide the Federal T... 
01/30/2007Express Scripts Schedules Fourth Quarter Earnings Release and Conference Call
ST. LOUIS--(BUSINESS WIRE)--Jan. 30, 2007--Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, will report its fourth quarter 2006 results and comment on its 2007 earnings guidance prior to the market opening on Thursday, February 8, 2007. Express Scripts will hold its quarterly conference call to discuss these results on that same day, beginning at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). The conference call can... 
01/24/2007Express Scripts to Distribute Definitive Proxy Materials to Caremark Stockholders
Express Scripts Urges Caremark Stockholders to Vote the GOLD Proxy Card Against the Acquisition By CVS ST. LOUIS, Jan. 24 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it will commence distributing its definitive proxy materials to all Caremark Rx, Inc. (NYSE: CMX) stockholders in connection with Caremark's special meeting of stockholders to be held on February 20, 2007. Express Scripts also announced that it will distri... 
01/16/2007Express Scripts Comments on CVS-Caremark Announcement
The Express Scripts Offer for Caremark Remains Superior ST. LOUIS, Jan. 16 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today issued the following statement in response to the announcement by Caremark Rx, Inc., (NYSE: CMX) and CVS Corporation (NYSE: CVS). The Express Scripts offer for Caremark remains superior. Express Scripts noted that the recent steps taken by Caremark and CVS are no more than a desperate attempt to save a flawed transaction: ... 
01/16/2007Express Scripts Announces Exchange Offer for Caremark
ST. LOUIS, Jan. 16 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it is commencing an exchange offer for all outstanding shares of Caremark Rx, Inc., (NYSE: CMX) in furtherance of Express Scripts' previously announced proposal to acquire Caremark. The complete terms, conditions and other details of the Exchange Offer are set forth in the offering documents that Express Scripts will file later today with the Securities and Exchange Commission. ... 
01/08/2007Express Scripts Nominates Four Directors for the Caremark Board of Directors
Express Scripts Offer for Caremark is Superior ST. LOUIS, Jan. 8 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it provided notice to Caremark Rx, Inc., (NYSE: CMX) of its intention to nominate four candidates for election to the Caremark Board of Directors at the Company's upcoming Annual Meeting of Stockholders. On December 18, 2006, Express Scripts announced its proposal to acquire Caremark for $29.25 in cash and 0.426 shares... 
01/08/2007Express Scripts Offer for Caremark is Superior
ST. LOUIS, Jan. 8 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) today issued the following statement in response to the announcement by Caremark Rx, Inc. (NYSE: CMX) that its Board of Directors has rejected the Express Scripts offer: "Our offer represents a superior proposal. Caremark stockholders and the marketplace as a whole have demonstrated their strong support for our offer, which clearly provides Caremark stockholders with superior value to the proposed ac... 
01/04/2007Express Scripts Sends Letter to Caremark Stockholders
ST. LOUIS, Jan 04, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Express Scripts, Inc. (Nasdaq: ESRX) today sent the following letter to Caremark Rx, Inc. (NYSE: CMX) stockholders: January 4, 2007 PROTECT YOUR CAREMARK INVESTMENT VOTE AGAINST THE PROPOSED CVS MERGER Dear Caremark Stockholder: On November 1, 2006, Caremark Rx, Inc. and CVS Corporation announced a transaction whereby CVS would acquire all of the outstan... 
Print Page Print | E-mail Page E-mail Page | RSS Feeds RSS | E-mail Alerts Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet